https://scholars.lib.ntu.edu.tw/handle/123456789/624464
標題: | Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma | 作者: | Liu, Chang-Hsien Peng, Cheng-Ming Hwang, Jen-I PO-CHIN LIANG PEI-JER CHEN Abi-Jaoudeh, Nadine Giiang, Lung-Hui Tyan, Yu-Shen |
關鍵字: | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DRUG-ELUTING BEADS; CANCER STEM-CELLS; TRANSARTERIAL CHEMOEMBOLIZATION; RANDOMIZED-TRIAL; LIVER-TUMORS; III TRIAL; EMBOLIZATION; HYPOXIA; CISPLATIN | 公開日期: | 2022 | 出版社: | ELSEVIER SCIENCE INC | 卷: | 33 | 期: | 8 | 起(迄)頁: | 926 | 來源出版物: | Journal of vascular and interventional radiology : JVIR | 摘要: | To investigate the safety of replacing doxorubicin with tirapazamine in conventional transarterial chemoembolization (TACE) in an Asian population with hepatocellular carcinoma (HCC), and to determine the optimal tirapazamine dose for phase II studies. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/624464 | ISSN: | 1051-0443 | DOI: | 10.1016/j.jvir.2022.04.031 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。